Advertisement Fidelity
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator flaflyersfan, Doubledown22, Stock Barber, vikingzskillz, Valiant, Badali
Search This Board:
Last Post: 4/17/2014 6:42:18 PM - Followers: 319 - Board type: Free - Posts Today: 15
(This "Intro Box" is NOT maintained byEPGL Medical Sciences and is intended solely as a quick information source on ihub.  For more detailed, up-to-date information on EPGL Medical Sciences,  please go the company website by clicking the link above..)

Company Summary

EP Global Communications, Inc. (ticker EPGL) will change its name to EPGL Medical Sciences, Inc. in early 2013. EPGL Medical Sciences, Inc. is a new biomedical device manufacturing and marketing company. The Company is focused on developing and marketing medical devices for both diagnosis and treatment of chronic pain. EPGL Med's first medical device, the MPDD, will be released in 2013 to awaiting physicians worldwide. The FDA cleared MPDD medical device can help physicians detect the exact point of pain origination in muscles as never before. The Company is currently working to invent and develop additional cutting edge medical device technology products to introduce subsequently to the MPDD, including biomedical devices which utilize Bio-Micro-Electro Mechanical Systems technology (Bio-MEMS). Bio-MEMS is one of the fastest growing and promising new frontiers in medical technology today with possibilities in both medical diagnostic and treatment applications. 

EPGL Medical Science's Competitive Edge

As of July 27, 2012, EP Global Communications, Inc. (EPGL) has successfully been restructured by Pricewaterhouse Coopers (PwC), which is the world's largest financial accounting firm.   PwC, along with all other major debt holders, have converted 100% of the Company's debt to equity, estimated to be $10 million USD, becoming major equity partners in the Company.  Via the restructuring and as previously announced in public statements, EPGL will now move ahead with plans to enter the growing medical device industry.  EPGLD, through acquisition, now holds rights to at least one FDA 510k cleared medical device.  The Company recently announced it has appointed Corey W. Hunter M.D. as Company Medical Director and Chairman of the Scientific Advisory Board.

EPGL Medical Sciences, Inc. is a medical device manufacturer and marketing company with exclusive rights to a new FDA 510k cleared medical device called the Muscle Pain Detection Device. The MPDD is a revolutionary new diagnostic tool for the detection of muscular originated pain in the human body.  The combined national and international market for the MPDD device is estimated at $4.5 billion dollars annually in device sales and recurrent education and training revenues.

EPGL Medical Science's Latest Developments

EPGL Medical Science's will be among the first Medical Device Makers to Implement Google Glass technology and the API Mirror platform for use with its medical devices. EPGL has several new devices in development which are being developed with the latest smart platforms in mind. "Physicians using our devices will be able to utilize technology such as Google Glass while performing procedures, using our devices and viewing feedback data in real-time.  In addition to integrating smart technology such as Google Glass, EPGL Medical now has a "secret weapon" medical device technology advancement which no other medical device company has. This single technology will be the catalyst for dozens of new medical device technologies to be produced or licensed by the Company. The Company is in the process of filing more than 50 patents to protect this unique and valuable innovation.

In addition to the new technologies EPGL is progressing, the Company is implementing an innovative new approach to medical device marketing with a business model which guarantees residual income from each new device sold. The Company's VIP approach to its physician customers with on-going technical support and educational training, will build strong loyalty to our medical devices.  EPGL  will reveal its new BioMEMS medical device platform, code named "TopSpin", during a series of conference calls hosted by David T. Markus Ph.D. this week. The calls will take place seven consecutive nights this week, starting Wednesday April 24 and concluding Tuesday April 30, 2013. As one of the top BioMEMS engineers in the world, Dr. Markus along with others, will unveil the importance and value of EPGL's new BioMEMS device platform in today's medical marketplace. The new technology stands to spawn potentially dozens of new medical devices, giving doctors innovative new tools for diagnosis and treatment.

About EPGL Medical Science's Share Structure

EPGL has a share structure of 5 billion authorised shares with approximately 4.5 billion shares restricted and a float of approximately 499 million.  Following a very sucessfull Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 400%.  Tthe company has strongly stated many times that they will not sell shares into the retail market.  They are here to build a real company and impliment real growth.

SEC Filings
Share Structure
EPGL On Twitter
About the MPDD
EPGL Management Team

Contact EPGL Medical Sciences or, Phone: 877-287-6175

EPGL Medical Science's Press Release Highlights

1.  10:1 Reverse split to be voted upon by shareholders                                                                    
2. All major debt holders have agreed to convert 100% of the company's debt to equity 
3. Authorized shares will remain at the present level with no increase in shares
4. Exlusive rights to a medical device with FDA 510k clearance for marketing
5. New equity partners involved via merger
6. The acquisition will be in exchange for equity in the company resulting in no new debt to company
7. Current EPGL management will resign
8. New management with broad experience in the medical device industry will be assigned in coming weeks
9. Top Physicians and Scientists will be part of the new management
10. Proxy materials are being prepared and details will be mailed to shareholders about meeting in coming days

11. Reached a restructuring agreement with the liquidator of AJW funds to convert 100% of the Company's debt into equity
12. Restructure the Company into a medical device manufacturer
13. The Company will be given exclusive rights to a promising new medical device which has successfully achieved FDA 510k clearance in the pain diagnosis and management arena
14.   The Company plans to market the device to physicians, allied health care professionals and rehabilitation specialists worldwide
15. The potential market for this unique medical device is estimated to exceed $4.5 billion dollars annually
16. Current Company management will resign amicably
17. New management with broad experience in the medical device industry will be assigned, including top researchers, physicians and scientists
18. The Company name will change to EP Global Health Sciences, Inc.
19. Will retain the EPGL ticker symbol
20. The Company believes this restructuring agreement is an extremely positive development and will offer shareholders and investors the opportunity for a significant potential return on investment
21. Shareholders will be asked to approve a proposed reverse split of the Company's common stock so as to provide sufficient common shares for increased trading value and to raise funding necessary to implement the marketing plans and programs necessary for successful implementation of the new medical device business

EPGL Chart



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
EPGL News: PwC To Hold EPGL Equity 04/14/2014 01:42:00 PM
EPGL News: EPGL Proposes Reduction of Common Shares and Authorized Shares 02/12/2014 02:29:00 PM
EPGL News: EPGL Developing Wearable Tech 02/11/2014 10:41:00 AM
EPGL News: EPGL Technology Selected by Major Corporation for Development 12/16/2013 05:30:00 AM
#50469  Sticky Note EPGL Chart Read Doubledown22 02/18/14 08:58:29 PM
#50245  Sticky Note $EPGL DD Notes ~[/c Pro-Life 02/12/14 11:57:50 PM
#50026  Sticky Note EPGL TIMELINE w/Links. FULL DD. This H8ster 02/04/14 05:02:30 PM
#51622   mfefree, it has been 506 days since EPGL flaflyersfan 04/17/14 06:42:18 PM
#51621   Ditto. This is getting hotter and this goodboy2 04/17/14 05:42:55 PM
#51620   Ditto, smack the ask monday morning. TURN goodboy2 04/17/14 05:41:37 PM
#51619   Anyone not excited about the future of EPGLmed TrickV8 04/17/14 05:37:51 PM
#51618   The volume is Boooorring! davidr2448 04/17/14 05:14:09 PM
#51617   What did they tell us: Bellied 04/17/14 04:04:42 PM
#51616   These guys done took our cash and ran Doubledown22 04/17/14 04:04:05 PM
#51615   you are right, they do release info but Bellied 04/17/14 03:47:53 PM
#51614   A couple of issues are beginning to concern mfefree 04/17/14 03:43:03 PM
#51613   Say what you like about EPGL, one thing PennyPinched 04/17/14 02:55:43 PM
#51612   Research bioMEMS and wearable tech for medical purposes. H8ster 04/17/14 01:46:36 PM
#51611   Everyone keeps saying this stock is valued at 1believe 04/17/14 11:59:54 AM
#51609   You should have noticed the green checked "Company wobblenuts 04/17/14 09:20:06 AM
#51608   Yes,thank you for showing. eikel 04/17/14 04:15:03 AM
#51607   At least it only takes me about 5 gman22 04/16/14 04:48:10 PM
#51606   Yes, that's what I meant. PennyPinched 04/16/14 04:29:45 PM
#51605   You mean Q1 2014 and FY 2013 annual? wobblenuts 04/16/14 04:19:39 PM
#51604   Anyone know when we might expect the 4Q PennyPinched 04/16/14 03:57:11 PM
#51603   A-Holes hiding best bid again today....this thing is Doubledown22 04/16/14 03:13:20 PM
#51602   eikel, other than the Chill removal and the flaflyersfan 04/16/14 08:56:42 AM
#51601   Here you have the article with the photo: eikel 04/16/14 03:58:00 AM
#51600   No...I've thought that before and as soon as gman22 04/15/14 10:04:42 PM
#51599   Let's hope so....dollars would make most of us gman22 04/15/14 10:01:58 PM
#51598   I hope this takes off soon. Still gman22 04/15/14 09:45:26 PM
#51597   Thanks. PennyPinched 04/15/14 03:25:15 PM
#51596   Turds are hiding bids and slow walking Doubledown22 04/15/14 03:13:22 PM
#51595   Yep...but it's kinda nice seeing that .03, even shakamac 04/15/14 03:12:38 PM
#51594   ETRF, NITE and ATDF are on the ask Bellied 04/15/14 03:02:35 PM
#51593   That's what I'm seeing also...but nothing after that shakamac 04/15/14 02:57:27 PM
#51592   90K / 176K 0.0166/0.019 Bellied 04/15/14 02:48:51 PM
#51591   L2 please anyone? PennyPinched 04/15/14 02:20:51 PM
#51590   Yes and they better get in line to PennyPinched 04/15/14 12:37:20 PM
#51589   Agree with you. Also that was some time moneyguy 04/15/14 11:45:05 AM
#51588   I'm in the same one and I hope DBS 04/15/14 10:46:47 AM
#51587   Dbs, I am heavily invested in other one kura 04/15/14 10:36:00 AM
#51586   Agreed kura! This could blow up very soon! DBS 04/15/14 10:30:32 AM
#51585   If Epgl gets 100% successful in smart contact kura 04/15/14 10:20:13 AM
#51584   Is EPGL attending this? jhnvtjll 04/15/14 10:13:38 AM
#51583   Dr. Markus holds patents related to this. wobblenuts 04/15/14 10:12:08 AM
#51582   Isn't there really only one company touting their Valiant 04/15/14 10:07:37 AM
#51581   Amazing..... When technology is known and understood by vikingzskillz 04/15/14 10:05:18 AM
#51580   Those of us that believe and stay the vikingzskillz 04/15/14 10:03:26 AM
#51579   connect the dots... :-) Gatsby 04/15/14 10:03:11 AM
#51578   tweets today: Gatsby 04/15/14 09:57:25 AM
#51577   Agreed! DBS 04/15/14 09:54:48 AM
#51576   Totally agree! The question I want to Valiant 04/15/14 09:53:29 AM
#51575   News expresses the faith PWC has in EPGL! Roberto7 04/15/14 09:48:53 AM
#51574   This is AWESOME!!! Anyone saying otherwise is completely vikingzskillz 04/15/14 09:41:41 AM
#51573   Well, who's eye did you want to see, wobblenuts 04/15/14 09:36:02 AM
#51571   I doubt they are going to post a Valiant 04/15/14 09:28:09 AM